HIV: Epidemiology and strategies for therapy and vaccination

Intervirology

Volumn 45, Issue 4-6, 2002, Pages 260-266

  Marcus, Ulrich ^a   Dittmar, Matthias T ^b   Kräusslich, Hans Georg ^b  

^a ROBERT KOCH INSTITUTE   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

AIDS; Epidemiology; HIV; Treatment; Vaccine

Indexed keywords

ANTIRETROVIRUS AGENT; DNA VACCINE; HUMAN IMMUNODEFICIENCY VIRUS FUSION INHIBITOR; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INTEGRASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CLINICAL TRIAL; CONFERENCE PAPER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; INFECTION PREVENTION; PRIORITY JOURNAL; VACCINATION;

AIDS VACCINES; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV INFECTIONS; HUMANS; VACCINATION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0036980075     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000067917     Document Type: Conference Paper

References (12)

1. Farmer P, Leandre F, Mukherjee JS, Claude M, Nevil P, Smith-Fawzi MC, Koenig SP, Castro A, Becerra MC, Sachs J, Attaran A, Kim JY: Community-based approaches to HIV treatment in resource-poor settings. Lancet 2001;358:404-409.
2. Phillips A: Will the drugs still work? Transmission of resistant HIV. Nat Med 2001;7:993-994.
3. Little SJ: Is transmitted drug resistance in HIV on the rise? It seems so. BMJ 2001;322:1074-1075.
4. Fidler S, Frater J, Clarke J, Weber J: HIV-1 drug resistance in primary infections in the UK. BMJ 2001;323:632-633.
5. Malim MH, Emerman M: HIV-1 sequence variation: Drift, shift, and attenuation. Cell 2001;104:469-472.
6. Nabel GJ: Challenges and opportunities for development of an AIDS vaccine. Nature 2001;410:1002-1007.
7. Barouch DH, Letvin NL: DNA vaccination for HIV-1 and SIV. Intervirology 2000;43:282-287.
8. Barouch DH, Santra S, Schmitz JE, Kuroda MJ, Fu TM, Wagner W, Bilska M, Craiu A, Zheng XX, Krivulka GR, Beaudry K, Lifton MA, Nickerson CE, Trigona WL, Punt K, Freed DC, Guan L, Dubey S, Casimiro D, Simon A, Davies ME, Chastain M, Strom TB, Gelman RS, Montefiori DC, Lewis MG, Emini EA, Shiver JW, Letvin NL: Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Science 2000;290:486-492.
9. Amara RR, Villinger F, Altman JD, Lydy SL, O'Neil SP, Staprans SI, Montefiori DC, Xu Y, Herndon JG, Wyatt LS, Candido MA, Kozyr NL, Earl PL, Smith JM, Ma HL, Grimm BD, Hulsey ML, Miller J, McClure HM, McNicholl JM, Moss B, Robinson HL: Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science 2001;292:69-74.
10. Mugerwa RD, Kaleebu P, Mugyenyi P, Katongole-Mbidde E, Hom DL, Byaruhanga R, Salata RA, Ellner JJ: First trial of the HIV-1 vaccine in Africa: Ugandan experience. BMJ 2002;324:226-229.
11. Barouch DH, Kunstman J, Kuroda MJ, Schmitz JE, Santra S, Peyerl FW, Krivulka GR, Beaudry K, Lifton MA, Gorgone DA, Montefiori DC, Lewis MG, Wolinsky SM, Letvin NL: Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes. Nature 2002;415:335-339.
12. Lifson JD, Martin MA: One step forwards, one step back. Nature 2002;415:272-273.